Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable care

Ramesh Juneja and Rajeev Juneja, the brothers behind Mankind Pharma, have built one of India's top pharmaceutical companies with a distinctly mass-market focus.

Their growth journey has been marked by expansion across high-volume therapies such as anti-infectives, gastrointestinals and vitamins.

By closely tracking consumer needs, the Delhi-based company entered over-the-counter segment, creating popular brands such as Manforce condoms and PregaNews. A key strategic shift was an early entry into chronic therapies in 2004. In the past few years, it has launched a specialty business covering diabetes, cardiology, urology, neurology and respiratory diseases.


The company's approach to ramping up domestic manufacturing is aligned with the government's Make in India vision, including a focus on strong in-house manufacturing capabilities to deliver consistent quality at scale while ensuring cost efficiency and supply reliability.

Today, more than 75% of Mankind Pharma's manufacturing is in-house, including 32 production facilities. To boost domestic manufacturing, the company has completed a multi-year artificial intelligence-led transformation of its supply chain and strategic procurement functions.

"Our foundation has always been built on three simple principles-quality, affordability and accessibility.... We continue to invest in innovation, R&D (research and development) and digital capabilities while staying true to affordable healthcare," said chairman Ramesh Juneja. On the road ahead, he said: "We are expanding into chronic and specialty therapies, where the need for advanced yet accessible treatment is growing."

Commenting on the unique strengths of family-run companies, Rajeev Juneja, managing director and vice-chairman, said: "Family-owned enterprises bring a strong sense of long-term commitment and responsibility.... One of our key strengths is our ability to combine speed of execution with stability, taking bold strategic decisions while staying grounded in core values."